US MedTech Conference - EOI Australian Delegation
26th Apr 18
Australia’s innovative dental product manufacturers are invited to join the Australian delegation to the US MedTech Conference to be held in the United States over 23-26 September 2018.
Key Issues For The Dental Industry —
The US MedTech Conference is recognised globally as an opportunity to showcase outstanding innovative medical technologies, Australia's unique capabilities, and build invaluable inroads into international markets.
Every year the US MedTech Conference brings together thousands of medical technology professionals from North America and across the globe and provides intensive networking opportunities to connect with international specialists in policy, innovation, business development and investment. The MTPConnect australian pavilion will provide opportunity in a high-traffic area for participants to leverage Australian branding to attract research and development investment, engage in collaborative partnerships, and establish your company as a global leader in the medical technologies industry.
Participants in the Australian delegation will take advantage of tailored packages (to be confirmed) set to include benefits such as:
MPT Connect Australian Delegate Package Inclusions —
■. Discounted registration rates;
■. Access to programs and seminars exclusive to the Australian delegation, and invitation only events;
■. Tailored site visits with the Australian delegation;
■. Branding opportunities and exposure via MTPConnect Australian stand;
■. Promotion via Australian mission booklet;
■. Access to brochure stands;
■. Access to informal, open plan meeting areas on the stand;
■. Listing of company details on the MedTech Conference Directory.
MTPConnect is also working closely with conference organisers to pitch Australian delegates for speaking opportunities (i.e. the MedTech Innovator Showcase). Expressions of Interest are now open to join the delegation and discuss requirements – interested parties are encouraged to submit their EOI as soon as possible be involved in program planning.
The impressive US MedTech Conference agenda includes various networking sessions, receptions, plenary breakfast and lunch sessions, and educational programs including the CEOs Unplugged Series, panel sessions, and MedTech Meetups.
In 2017, MTPConnect led the largest international delegation at The Medtech Conference in San Jose. The Australian delegation took part in a tailored agenda of exclusive events including a tour of the Boston Scientific CRM manufacturing site, and presentations from the Medical Device Innovation Consortia, Hogan Lovells attorneys, Reimbursement Strategies LLC and Medical Alley on topics to learn from and assist in entering the US market.
This is an initiative of MTPConnect, a not-for-profit organisation which aims to accelerate the rate of growth of the medical technologies, biotechnologies and pharmaceuticals sector to achieve greater commercialisation and establish Australia as an Asia-Pacific hub for MTP companies. It was formed in November 2015 as part of the Federal Government’s $250 million Industry Growth Centres Initiative.
Member Engagement —
On matters associated with supporting innovative dental product manufacturers and suppliers the team within the ADIA National Office receive advice and guidance from members serving on the ADIA-MIG Manufacturers Interest Group. Frequent updates are provided to members that attend the quarterly series of ADIA State Branch Briefings.
Further Information —
For further information on ADIA's efforts to support Australia's innovative dental product manufacturers send an email to email@example.com or telephone 1300 943 094. To keep up to date follow ADIA on Facebook at www.facebook.com/dental.industry or subscribe to the Twitter feed @AusDental.
Currency Of Information & Disclaimer —
This update was issued on 26 April 2018 and please note that changes in circumstances after the publication of material or information may impact upon its accuracy and also change regulatory compliance obligations. The statements, regulatory and technical information contained herein are believed to be accurate and are provided for information purposes only. Readers are responsible for assessing its relevance and verifying the accuracy of the content. To the fullest extent permitted by law, ADIA will not be liable for any loss, damage, cost or expense incurred in relation to or arising as a result of relying on the information presented here.
This information is available for your use under a Creative Commons Attribution 3.0 Australia licence, with the exception of the ADIA logo, other images and where otherwise stated.
|A —.. A D I A . .S T R A T G E G I C . .A L L I A N C E S
11th Apr 18
As the TGA acts to introduce an application fee for placing Class 1 medical devices on the ARTG, ADIA has meet with senior ministerial advisors in order to seek an outcome to alleviate the impact on the dental industry.
7th Nov 17
SDI Limited has received a $10,000 fine for a determination that one of its promotions had influenced a healthcare professional to do other than select therapeutic products based upon genuine consumer health needs and clinical evidence